Your session is about to expire
← Back to Search
Miles de Manos Program for Domestic Violence Prevention (MdM Trial)
N/A
Waitlist Available
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in baseline parenting to about 1 year.
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a violence prevention program for Honduran elementary school students, to see how it impacts parents, teachers and student behavior. #prevention #violence #Honduras
Who is the study for?
This trial is for students in grades 3-5, their parents, and teachers from selected schools near Tegucigalpa, Honduras. Schools must be in urban or semi-urban areas with no previous use of the Miles de Manos program and show commitment from staff, leaders, and the community.
What is being tested?
The effectiveness of 'Miles de Manos', a violence prevention program for elementary school children in Honduras is being tested. It involves group sessions with parents/caregivers, teachers, and combined groups to reduce behavior problems.
What are the potential side effects?
Since this is a behavioral intervention focusing on violence prevention through educational programs rather than a medical treatment, it does not have typical side effects like drugs do.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in baseline parenting to about 1 year.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in baseline parenting to about 1 year.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from baseline child conduct problems to 6-9 months
Change from baseline child conduct problems to about 1 year post-baseline
Change from baseline child hyperactivity/inattention to 6-9 months
+32 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Miles de Manos (Thousands of Hands) InterventionExperimental Treatment1 Intervention
Parents and teachers from schools randomized to this arm will receive the Miles de Manos (Thousands of Hands) intervention. Miles de Manos (Thousands of Hands) comprises 3 components: a cognitive-behavioral skills training component for parents (8 sessions), a cognitive-behavioral skills training component for school staff (10 sessions), and a "bridge" component that brings parents, teachers, and school administrators together to talk about how to support each other's efforts related to youth violence prevention (4 sessions). Core elements include effective communication, clear expectations, limits and consequences, positive reinforcement, adult supervision and monitoring, effective problem solving, and emotion regulation. Miles de Manos (Thousands of Hands) is highly interactive and involves brief lectures, small and large group discussions, role-plays, and interactive exercises.
Group II: ControlActive Control1 Intervention
Parents and teachers from schools randomized to this arm will receive services as usual as provided by their schools.
Find a Location
Who is running the clinical trial?
University of Texas at AustinLead Sponsor
377 Previous Clinical Trials
83,575 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Miles de Manos (Thousands of Hands) Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.